RAFAEL HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Accounts Receivable of -$333.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-04-30 was -$1.00K, a 100.61% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-01-31 was -$118.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-10-31 was -$214.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-07-31 was $213.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $151.00K, a 0.67% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $150.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2021 was $161.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$87.00K, a 130.53% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$119.00K derived: sum of 2 quarters · filed 2026-06-11 | -$333.00K 10-Q · filed 2026-06-11 | -$120.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2026-01-31 | -$118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$332.00K 10-Q · filed 2026-03-16 | -$119.00K derived: sum of 3 quarters · filed 2026-03-16 | $45.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-10-31 | -$214.00K 10-Q · filed 2025-12-12 | -$1.00K derived: sum of 2 quarters · filed 2025-12-12 | $163.00K derived: sum of 3 quarters · filed 2026-06-11 | $162.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-07-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $377.00K derived: sum of 2 quarters · filed 2026-06-11 | $376.00K derived: sum of 3 quarters · filed 2026-06-11 | $151.00K 10-K · filed 2025-10-29 | |
| 2025-04-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $163.00K derived: sum of 2 quarters · filed 2026-06-11 | -$62.00K 10-Q · filed 2026-06-11 | -$79.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$226.00K 10-Q · filed 2026-03-16 | -$243.00K derived: sum of 3 quarters · filed 2026-03-16 | ||
| 2024-10-31 | -$225.00K 10-Q · filed 2025-12-12 | -$242.00K derived: sum of 2 quarters · filed 2025-12-12 | |||
| 2024-07-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $150.00K 10-K · filed 2025-10-29 | |||
| 2024-04-30 | $167.00K 10-Q · filed 2025-06-11 | ||||
| 2022-01-31 | -$78.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $418.00K 10-Q · filed 2022-03-17 | $781.00K derived: sum of 3 quarters · filed 2022-03-17 | $618.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2021-10-31 | $496.00K 10-Q/A · filed 2022-02-28 | $859.00K derived: sum of 2 quarters · filed 2022-02-28 | $696.00K derived: sum of 3 quarters · filed 2022-02-28 | $577.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2021-07-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $200.00K derived: sum of 2 quarters · filed 2021-10-18 | $81.00K derived: sum of 3 quarters · filed 2022-03-17 | $161.00K 10-K · filed 2021-10-18 | |
| 2021-04-30 | -$163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | -$282.00K derived: sum of 2 quarters · filed 2022-03-17 | -$202.00K 10-Q · filed 2021-06-14 | -$148.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2021-01-31 | -$119.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | -$39.00K 10-Q · filed 2022-03-17 | $15.00K derived: sum of 3 quarters · filed 2022-03-17 | -$49.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-10-31 | $80.00K 10-Q/A · filed 2022-02-28 | $134.00K derived: sum of 2 quarters · filed 2022-02-28 | $70.00K derived: sum of 3 quarters · filed 2022-02-28 | $166.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-07-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$10.00K derived: sum of 2 quarters · filed 2021-10-18 | $86.00K derived: sum of 3 quarters · filed 2021-10-18 | -$87.00K 10-K · filed 2021-10-18 | |
| 2020-04-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $32.00K derived: sum of 2 quarters · filed 2021-06-14 | -$141.00K 10-Q · filed 2021-06-14 | $141.00K 10-Q · filed 2020-06-09 | $615.00K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-01-31 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | -$77.00K 10-Q · filed 2021-03-17 | $679.00K derived: sum of 3 quarters · filed 2021-03-17 | $130.00K derived: sum of 4 quarters · filed 2021-03-17 | |
| 2019-10-31 | -$173.00K 10-Q · filed 2020-12-15 | $583.00K derived: sum of 2 quarters · filed 2020-12-15 | $34.00K derived: sum of 3 quarters · filed 2020-12-15 | $20.00K derived: sum of 4 quarters · filed 2020-12-15 | |
| 2019-07-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $207.00K derived: sum of 2 quarters · filed 2020-10-29 | $193.00K derived: sum of 3 quarters · filed 2020-10-29 | $285.00K 10-K · filed 2020-10-29 | |
| 2019-04-30 | -$549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | -$563.00K derived: sum of 2 quarters · filed 2020-06-09 | -$471.00K 10-Q · filed 2020-06-09 | $471.00K 10-Q · filed 2019-06-05 | -$590.00K derived: sum of 4 quarters · filed 2020-06-09 |
| 2019-01-31 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | $78.00K 10-Q · filed 2020-03-05 | -$41.00K derived: sum of 3 quarters · filed 2020-03-05 | $139.00K derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-10-31 | $92.00K 10-Q · filed 2019-12-09 | -$27.00K derived: sum of 2 quarters · filed 2019-12-09 | $153.00K derived: sum of 3 quarters · filed 2019-12-09 | $27.00K derived: sum of 4 quarters · filed 2019-12-09 | |
| 2018-07-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $61.00K derived: sum of 2 quarters · filed 2019-10-04 | -$65.00K derived: sum of 3 quarters · filed 2019-10-04 | $23.00K 10-K · filed 2019-10-04 | |
| 2018-04-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $54.00K derived: sum of 2 quarters · filed 2019-06-05 | $142.00K 10-Q · filed 2019-06-05 | $109.00K derived: sum of 4 quarters · filed 2019-06-05 | |
| 2018-01-31 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | -$38.00K 10-Q · filed 2019-03-12 | -$71.00K derived: sum of 3 quarters · filed 2019-03-12 | -$110.00K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-10-31 | $88.00K 10-Q · filed 2018-12-10 | $55.00K derived: sum of 2 quarters · filed 2018-12-10 | $16.00K derived: sum of 3 quarters · filed 2018-12-10 | ||
| 2017-07-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | -$72.00K derived: sum of 2 quarters · filed 2018-10-15 | $7.00K 10-K · filed 2018-10-15 | ||
| 2017-04-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $40.00K 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | $79.00K 10-Q · filed 2018-03-12 | ||||
| 2016-07-31 | $109.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |